Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change | Zendy

Beatrice Detti | Zendy; Gianluca Ingrosso | Zendy; Carlotta Becherini | Zendy; Andrea Lancia | Zendy; Emanuela Olmetto | Zendy; Emanuele Alì | Zendy; Simona Marani | Zendy; Maria Ausilia Teriaca | Zendy; Giulio Francolini | Zendy; Angela Sardaro | Zendy; Cynthia Aristei | Zendy; Andrea Riccardo Filippi | Zendy; Giuseppe Sanguineti | Zendy; Lorenzo Livi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change

Author(s) -

Beatrice Detti,

Gianluca Ingrosso,

Carlotta Becherini,

Andrea Lancia,

Emanuela Olmetto,

Emanuele Alì,

Simona Marani,

Maria Ausilia Teriaca,

Giulio Francolini,

Angela Sardaro,

Cynthia Aristei,

Andrea Riccardo Filippi,

Giuseppe Sanguineti,

Lorenzo Livi

Publication year - 2021

Publication title -

cancer treatment and research communications

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.459

H-Index - 10

ISSN - 2468-2942

DOI - 10.1016/j.ctarc.2021.100331

Subject(s) - medicine , radiation therapy , prostate cancer , watchful waiting , androgen deprivation therapy , oncology , malignancy , cryoablation , prostate , cancer , ablation

Management of prostate cancer should be adapted in response to the COVID-19 pandemic. A practical additional document on treatment of this tumor was developed in according to the recent recommendations of the European Association of Urology. In conclusion, the challenge should concern a correct management of the oncologic patient, reducing the risk of spreading the virus without worsening tumor prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research